ATIF Holdings Limited Addresses Recent Stock Volatility
07 août 2019 09h00 HE
|
ATIF Holdings Ltd
SHENZHEN, China, Aug. 07, 2019 (GLOBE NEWSWIRE) -- ATIF Holdings Limited (“ATIF”, or the “Company”), a company providing financial consulting services to small and medium-sized enterprises in Asia,...
Holding(s) in Company
15 janv. 2019 12h45 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Holding(s) in Company
10 janv. 2019 11h15 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Holding(s) in Company
10 janv. 2019 06h30 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Holding(s) in Company
09 janv. 2019 11h45 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Holding(s) in Company
02 janv. 2019 04h40 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Holding(s) in Company
18 déc. 2018 07h15 HE
|
Summit Therapeutics plc
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the...
Total voting rights
03 sept. 2018 06h00 HE
|
Summit Therapeutics plc
Summit Therapeutics plc(‘the Company’) Total voting rights Oxford, UK, and Cambridge, MA, US 3 September 2018 – Summit Therapeutics plc (AIM:SUMM, NASDAQ:SMMT), announces that in accordance with the...